Advertisement

Topics

Anti-LAG-3 in Combination with Opdivo Show Activity in Patients with Melanoma Who Failed Anti-PD-1/PD-L1 Therapy

20:01 EDT 30 Jul 2017 | Cancer Connect

For some cancers immunotherapy is becoming a standard of care, but there are growing numbers of patients who are refractory […]

The post Anti-LAG-3 in Combination with Opdivo Show Activity in Patients with Melanoma Who Failed Anti-PD-1/PD-L1 Therapy appeared first on .

Original Article: Anti-LAG-3 in Combination with Opdivo Show Activity in Patients with Melanoma Who Failed Anti-PD-1/PD-L1 Therapy

NEXT ARTICLE

More From BioPortfolio on "Anti-LAG-3 in Combination with Opdivo Show Activity in Patients with Melanoma Who Failed Anti-PD-1/PD-L1 Therapy"

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...